These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 16739070

  • 1. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.
    Barthomeuf C, Demeule M, Grassi J, Saidkhodjaev A, Beliveau R.
    Planta Med; 2006 Jun; 72(7):634-9. PubMed ID: 16739070
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C, Grassi J, Demeule M, Fournier C, Boivin D, Béliveau R.
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
    [Abstract] [Full Text] [Related]

  • 3. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME, Podila L, Ely D, Almeida I.
    Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
    Cardarelli CO, Aksentijevich I, Pastan I, Gottesman MM.
    Cancer Res; 1995 Mar 01; 55(5):1086-91. PubMed ID: 7866993
    [Abstract] [Full Text] [Related]

  • 5. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
    Mi Q, Cui B, Silva GL, Lantvit D, Lim E, Chai H, You M, Hollingshead MG, Mayo JG, Kinghorn AD, Pezzuto JM.
    Cancer Res; 2001 May 15; 61(10):4030-7. PubMed ID: 11358822
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract.
    Limtrakul P, Khantamat O, Pintha K.
    Cancer Chemother Pharmacol; 2004 Dec 15; 54(6):525-30. PubMed ID: 15248030
    [Abstract] [Full Text] [Related]

  • 7. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.
    Lee CG, Gottesman MM, Cardarelli CO, Ramachandra M, Jeang KT, Ambudkar SV, Pastan I, Dey S.
    Biochemistry; 1998 Mar 17; 37(11):3594-601. PubMed ID: 9530286
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport.
    Evers R, Kool M, Smith AJ, van Deemter L, de Haas M, Borst P.
    Br J Cancer; 2000 Aug 17; 83(3):366-74. PubMed ID: 10917553
    [Abstract] [Full Text] [Related]

  • 9. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
    Yasuda K, Lan LB, Sanglard D, Furuya K, Schuetz JD, Schuetz EG.
    J Pharmacol Exp Ther; 2002 Oct 17; 303(1):323-32. PubMed ID: 12235267
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of xenobiotic efflux transporters in resistance to vincristine.
    Huang RS, Murry DJ, Foster DR.
    Biomed Pharmacother; 2008 Feb 17; 62(2):59-64. PubMed ID: 17583464
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis, molecular structure, and validation of metalloprobes for assessment of MDR1 P-glycoprotein-mediated functional transport.
    Sivapackiam J, Harpstrite SE, Prior JL, Gu H, Rath NP, Sharma V.
    Dalton Trans; 2010 Jul 07; 39(25):5842-50. PubMed ID: 20505882
    [Abstract] [Full Text] [Related]

  • 15. (+/-)-3'-O, 4'-O-dicynnamoyl-cis-khellactone, a derivative of (+/-)-praeruptorin A, reverses P-glycoprotein mediated multidrug resistance in cancer cells.
    Shen X, Chen G, Zhu G, Fong WF.
    Bioorg Med Chem; 2006 Nov 01; 14(21):7138-45. PubMed ID: 16875827
    [Abstract] [Full Text] [Related]

  • 16. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.
    Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM.
    Cancer Res; 1993 Mar 01; 53(5):977-84. PubMed ID: 8094997
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport.
    Kuteykin-Teplyakov K, Luna-Tortós C, Ambroziak K, Löscher W.
    Br J Pharmacol; 2010 Jul 01; 160(6):1453-63. PubMed ID: 20590635
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multidrug resistance-reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis.
    Arboix M, Paz OG, Colombo T, D'Incalci M.
    J Pharmacol Exp Ther; 1997 Jun 01; 281(3):1226-30. PubMed ID: 9190857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.